Related Experiment Video
Updated: Jul 22, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Apoptin-induced apoptosis: a review
1Leadd BV and Department of Molecular Cell Biology, Leiden University Medical Center, Wassenaarseweg 72, 2300 RA Leiden, The Netherlands. noteborn@leadd.nl
Abstract:
Apoptin, a protein encoded by an avian virus, induces apoptosis in various cultured human tumorigenic and/ or transformed cell lines, e.g. derived from breast and lung tumor, leukemia, lymphoma, osteosarcoma melanoma, cholangiocarcinoma, and hepatoma. In such cells, Apoptin induces p53-independent apoptosis, and the proto-oncogene Bcl-2 can accelerate this effect. The latter is surprising for, in general, Bcl-2 is known to inhibit e.g., p53-induced apoptosis. On the other hand, in normal non-transformed human cells, Apoptin is unable to induce apoptosis, even when Bcl-2 is over-expressed. In animal models Apoptin-induced apoptosis appears to be a safe and efficient anti-tumor agent. These data, in continuation with the observations that Apoptin is specifically stimulated by Bcl-2 in tumor cells, does not need p53, and is not inhibited by Bcr-Abl in these cells, imply that Apoptin is a potential anti-tumor therapy.
Insights
Apoptin, a viral protein, selectively triggers cancer cell death (apoptosis) independently of p53. This protein shows promise as a safe and effective anti-tumor therapy, particularly in animal models.
Area of Science:
- Oncology
- Molecular Biology
- Virology
Background:
- Apoptin is a protein derived from an avian virus with demonstrated ability to induce apoptosis.
- Apoptosis is a critical cellular process for eliminating damaged or unwanted cells, and its dysregulation is a hallmark of cancer.
- The proto-oncogene Bcl-2 typically inhibits apoptosis, but its interaction with Apoptin presents a unique scenario.
Purpose of the Study:
- To investigate the mechanism of Apoptin-induced apoptosis in various human tumor cell lines.
- To determine the role of p53 and Bcl-2 in Apoptin's apoptotic activity.
- To evaluate the therapeutic potential of Apoptin as an anti-cancer agent in preclinical models.
Main Methods:
- Culturing various human tumorigenic and transformed cell lines (breast, lung, leukemia, lymphoma, osteosarcoma, melanoma, cholangiocarcinoma, hepatoma).
- Treating cell lines with Apoptin and assessing apoptosis induction.
- Over-expressing Bcl-2 in normal and tumor cells to study its effect on Apoptin activity.
- Evaluating Apoptin's efficacy and safety in animal models.
Main Results:
- Apoptin induced p53-independent apoptosis in diverse human tumor cell lines.
- The proto-oncogene Bcl-2 accelerated Apoptin-induced apoptosis in tumor cells, contrary to its general inhibitory role.
- Apoptin did not induce apoptosis in normal human cells, even with Bcl-2 over-expression.
- Apoptin demonstrated safe and efficient anti-tumor activity in animal models.
Conclusions:
- Apoptin selectively targets tumor cells for apoptosis, sparing normal cells.
- The p53-independent and Bcl-2-accelerated apoptotic pathway makes Apoptin a unique anti-cancer therapeutic candidate.
- Apoptin represents a promising novel anti-tumor therapy with a favorable safety profile.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy

